The matrix metalloproteinase system in oral squamous cell carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 44, Issue 6, 2006, Pages 482-486

  Baker, E A ^a   Leaper, D J ^a   Hayter, J P ^b   Dickenson, A J ^c  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

Head and neck cancer; Metastasis; Proteinase inhibitors; Proteinases; Tissue inhibitors of metalloproteinase (TIMP)

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION KINETICS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MOUTH CARCINOMA; ORAL BIOPSY; ORAL SURGERY; PATHOLOGICAL ANATOMY; RANK SUM TEST; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; GELATINASES; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33750433937     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2005.10.005     Document Type: Article

References (29)

1. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., and Steele R.J. Matrix metalloproteinases. Br J Surg 84 (1997) 160-166
2. Sorsa T., Tjaderhane L., and Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10 (2004) 311-318
3. Raza S.L., and Cornelius L.A. Matrix metalloproteinases: pro and anti-angiogenic activities. J Invest Dermatol Symp Proc 5 (2000) 47-54
4. Ray J.M., and Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7 (1995) 2062-2072
5. Ennis B.W., and Matrisian L.M. Matrix degrading metalloproteinases. J Neurooncol 18 (1994) 105-198
6. Birkedal-Hansen B., Pavelic Z.P., Gluckman J.L., Stambrook P., Li Y.-Q., and Stetler-Stevenson W.G. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis 6 (2000) 376-382
7. Guttman D., Stern Y., Shpitzer T., Ulanovski D., Druzd T., and Feinmesser R. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 40 (2004) 798-803
8. Yoshizaki T., Sato H., Maryama Y., Murono S., Furukawa M., Park S.C., et al. Increased expression of membrane type-1 matrix metalloproteinase in head and neck carcinoma. Cancer 79 (1997) 139-144
9. Rosenthal E.L., Hotary K., Bradford C., and Weiss S.J. Role of membrane type-1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro. Otolaryngol Head Neck Surg 12 (1999) 337-343
10. Ikebe T., Shinohara M., Takeuchi H., Beppu M., Kurahara S., Nakamura S., et al. Gelatinolytic activity of matrix metalloproteinase in tumour tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17 (1999) 315-323
11. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., and Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 99 (1993) 18-23
12. Kusukawa J., Sasaguri Y., Morimatsu M., and Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 53 (1995) 530-534
13. Pacheco M.M., Kowalski L.P., Nishimoto I.N., and Brentani M.M. Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B and matrilysin mRNAs. Head Neck 24 (2002) 24-32
14. Franchi A., Santucci M., Masini E., Sardi I., Pagierani M., and Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2 and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95 (2002) 1902-1910
15. Nagel H., Lasakawi R., Wahlers A., and Hemmerlein B. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2 and -3 in benign and malignant tumours of the salivary gland. Histopathology 44 (2004) 222-231
16. Ikebe T., Shinohara M., Takeuchi H., et al. Gelatinocytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17 (1999) 315-323
17. Katayama A., Bandoh N., Kishibe K., et al. Expressions of matrix metalloproteinases in early stage oral squamous cell carcinoma as predictive indicators for tumour metastases and prognosis. Clin Cancer Res 10 (2004) 634-640
18. Kurahara S.I., Shinohara M., Ikebe T., et al. Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumour invasion and metastasis. Head Neck 21 (1999) 627-638
19. Ohnishi S.T., and Barr J.K. A simplified method of quantifying proteins using the biuret and phenol reagents. Anal Biochem 86 (1978) 193-200
20. Baker E.A., and Leaper D.J. Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 28 (2002) 24-29
21. Knight C.G., Willenbrock F., and Murphy G. A novel coumarin labelled peptide for sensitive continuous assays of matrix metalloproteinases. FEBS Lett 296 (1992) 263-266
22. Garbett E.A., Reed MWR, and Brown N.J. Proteolysis in colorectal cancer. Mol Pathol 52 (1999) 140-145
23. Schmidt M., Polednik C., and Hoppe F. Proteolytic patterns of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 256 (1999) 346-350
24. Kayano K., Shimada T., Shinomiya T., et al. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J Pathol 202 (2004) 403-411
25. Sutinen M., Kainulainen T., Hurskainen T., et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 77 (1998) 2239-2245
26. Culhaci N., Metin K., Copcu E., and Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer 4 (2004) 42
27. Myoung H., Kim M.J., Hong S.D., et al. Expression of membrane type 1-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett 185 (2002) 201-209
28. Shimada T., Nakamura H., Yamashita K., et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis. Clin Exp Metastasis 18 (2000) 179-188
29. Thomas G.T., Lewis M.P., and Speight P.M. Matrix metalloproteinases and oral cancer. Oral Oncol 35 (1999) 227-233